YILDIRIM, T. Et Al. 2012. Are low-molecular-weight heparins appropriately dosed in patients with CKD stage 3 to 5?. BLOOD COAGULATION & FIBRINOLYSIS , vol.23, no.8 , 700-704.

YILDIRIM, T., Kocak, T., BÜYÜKAŞIK, Y., Yilmaz, R., Altun, B., Erdem, Y., ... Arici, M.(2012). Are low-molecular-weight heparins appropriately dosed in patients with CKD stage 3 to 5?. BLOOD COAGULATION & FIBRINOLYSIS , vol.23, no.8, 700-704.

YILDIRIM, TOLGA Et Al. "Are low-molecular-weight heparins appropriately dosed in patients with CKD stage 3 to 5?," BLOOD COAGULATION & FIBRINOLYSIS , vol.23, no.8, 700-704, 2012

YILDIRIM, TOLGA Et Al. "Are low-molecular-weight heparins appropriately dosed in patients with CKD stage 3 to 5?." BLOOD COAGULATION & FIBRINOLYSIS , vol.23, no.8, pp.700-704, 2012

YILDIRIM, T. Et Al. (2012) . "Are low-molecular-weight heparins appropriately dosed in patients with CKD stage 3 to 5?." BLOOD COAGULATION & FIBRINOLYSIS , vol.23, no.8, pp.700-704.

@article{article, author={TOLGA YILDIRIM Et Al. }, title={Are low-molecular-weight heparins appropriately dosed in patients with CKD stage 3 to 5?}, journal={BLOOD COAGULATION & FIBRINOLYSIS}, year=2012, pages={700-704} }